Skip to main content
Contact Us
Subscribe
E-Edition
84°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about SRPT
Recent news which mentions SRPT
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO
March 08, 2024
Tickers
NEWS
PFE
RGNX
SRPT
Tags
Upgrades
Briefs
Biotech
From
Benzinga
Got $1,000? Buy These Hot Growth Stocks Before They Take Off.
March 08, 2024
Tickers
ENPH
GOOG
GOOGL
SRPT
Tags
GOOG
SRPT
Market News
From
Motley Fool
Sarepta Therapeutics Stock Has 73% Upside, According to 1 Wall Street Analyst
March 04, 2024
Tickers
SRPT
Tags
Market News
Recent Press Releases
SRPT
From
Motley Fool
Sarepta Therapeutics (SRPT) Q4 2023 Earnings Call Transcript
February 29, 2024
Tickers
SRPT
Tags
Recent Press Releases
Market News
SRPT
From
Motley Fool
Sarepta Therapeutics: Q4 Earnings Insights
February 28, 2024
Tickers
SRPT
Tags
Benzinga
Market News
BZI/Recaps
From
Benzinga
Is It Too Late to Buy Sarepta Therapeutics Stock?
February 28, 2024
Tickers
SRPT
Tags
SRPT
Recent Press Releases
Market News
From
Motley Fool
Earnings Scheduled For February 28, 2024
February 28, 2024
Tickers
NOVT
NRG
NSA
NTNX
Tags
WHD
STEM
NOVT
From
Benzinga
A Preview Of Sarepta Therapeutics's Earnings
February 27, 2024
Tickers
SRPT
Tags
BZI/EP
Earnings
SRPT
From
Benzinga
Median Drug Prices For Rare Diseases Hit $300K In 2023, Report Highlights Lack of Clear Rationale Behind Escalating Drug Prices
February 26, 2024
Tickers
CRSP
NEWS
REGN
SRPT
Tags
CRSP
SRPT
Biotech
From
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
February 19, 2024
Tickers
ARQT
IOVA
LLY
MDT
Tags
ARQT
VTGN
PFE
From
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 19, 2024
Tickers
AMIX
AMN
AORT
BCLI
Tags
CLDI
Movers
BRNS
From
Benzinga
FDA Fast-Tracks Review Of Sarepta's Groundbreaking Muscular Dystrophy Treatment With $1B Market In Sight
February 16, 2024
Tickers
NEWS
RHHBY
SRPT
Tags
Health Care
Movers
RHHBY
From
Benzinga
Why DoorDash Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 16, 2024
Tickers
AMAT
AMBO
AMN
AORT
Tags
YJ
DASH
TDS
From
Benzinga
Why Sarepta Therapeutics Stock Is Soaring Today
February 16, 2024
Tickers
SRPT
Tags
SRPT
Market News
Recent Press Releases
From
Motley Fool
Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday
February 16, 2024
Tickers
AMAT
AORT
BIO
BLZE
Tags
TTD
Intraday Update
AMAT
From
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 16, 2024
Tickers
AMN
AORT
CDIO
HCTI
Tags
HCTI
Market News
HEPA
From
Benzinga
In-Depth Examination Of 13 Analyst Recommendations For Sarepta Therapeutics
February 15, 2024
Tickers
SRPT
Tags
SRPT
Market News
Benzinga
From
Benzinga
2 Magnificent Growth Stocks to Buy With $500
February 15, 2024
Tickers
SRPT
VEEV
Tags
SRPT
Recent Press Releases
VEEV
From
Motley Fool
Gene Therapy Player REGENXBIO's RGX-121 Marks Success In Trial, Yet Faces Challenges In A Crowded Market: Analyst
February 12, 2024
Tickers
DNLI
NEWS
PFE
RGNX
Tags
Health Care
RGNX
Trading Ideas
From
Benzinga
1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock?
February 11, 2024
Tickers
PTCT
SRPT
Tags
SRPT
PTCT
Recent Press Releases
From
Motley Fool
The Top 25 Stocks to Buy Immediately According to AI: February 2024 Edition
February 06, 2024
Tickers
ADP
AJG
AMGN
AMH
Tags
COIN
HESS
AMH
From
InvestorPlace
Assessing Sarepta Therapeutics: Insights From 12 Financial Analysts
January 30, 2024
Tickers
SRPT
Tags
SRPT
BZI/AAR
Benzinga
From
Benzinga
Sarepta Therapeutics' Next-Gen Duchenne Muscular Therapy Shows Efficacy At Less Frequent Dosing
January 29, 2024
Tickers
NEWS
SRPT
Tags
Market News
Health Care
News
From
Benzinga
Got $3,000? 3 Growth Stocks to Double Up On Right Now
January 26, 2024
Tickers
SRPT
SYM
UBER
Tags
SYM
SRPT
Market News
From
Motley Fool
Could Sarepta Therapeutics Become the Next Vertex Pharmaceuticals?
January 25, 2024
Tickers
SRPT
VRTX
Tags
SRPT
VRTX
Market News
From
Motley Fool
Why Sarepta Therapeutics Stock Zoomed Nearly 5% Higher Today
January 22, 2024
Tickers
JPM
SRPT
Tags
Recent Press Releases
Market News
SRPT
From
Motley Fool
Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market
January 16, 2024
Tickers
ATOS
SRPT
UTHR
Tags
SRPT
ATOS
NASDAQ:SRPT,NASDAQ:ATOS,NASDAQ:UTHR
From
InvestorPlace
A Closer Look at 14 Analyst Recommendations For Sarepta Therapeutics
January 10, 2024
Tickers
SRPT
Tags
Market News
Analyst Ratings
Benzinga
From
Benzinga
Stocks Flip To Losses, Nvidia Defies Gravity, Bitcoin Pauses For A Breather: What's Driving Markets Tuesday?
January 09, 2024
Tickers
AMD
BA
BITCOMP
DIA
Tags
Broad U/S/ Equity ETFs
RSP
OIH
From
Benzinga
Sarepta Expects Prelim Gene Therapy Revenue To Be $131M In Q4, $200M For Fiscal Year
January 09, 2024
Tickers
NEWS
SRPT
Tags
Briefs
Biotech
SRPT
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
